Meta Platforms

US · META #10 by market cap Listed 2012

705.44 -3.89 -0.55%

Live - 5344 symbols - heartbeat 335s ago · 2026-10-20 09:20

✦ Quant Financial Health how this is computed

Good

Altman Z-Score is 9.23, above the 3.0 "safe zone" threshold.
Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.

Revenue annual, last 8 years

Latest year +22.17% YoY

Margins

Gross margin: 82.00%
Operating margin: 41.44%
Net margin: 30.08%

Key ratios & quality

Enterprise value: 1.78T
PEG ratio: 0.71
Altman Z-Score: 9.23

PEG uses trailing P/E against the 3-year net income growth rate (37.61%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.

Income statement

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	55.84B	70.70B	85.97B	117.93B	116.61B	134.90B	164.50B	200.97B
Gross profit	46.48B	57.93B	69.27B	95.28B	91.36B	108.94B	134.34B	164.79B
Selling & admin expenses	11.30B	15.34B	18.16B	23.87B	27.08B	23.71B	21.09B	24.14B
Research & development	10.27B	13.60B	18.45B	24.66B	35.34B	38.48B	43.87B	57.37B
Operating profit	24.91B	28.99B	32.67B	46.75B	28.94B	46.75B	69.38B	83.28B
Pretax profit	25.36B	24.81B	33.18B	47.28B	28.82B	47.43B	70.66B	85.93B
Tax	3.25B	6.33B	4.03B	7.91B	5.62B	8.33B	8.30B	25.47B
Net profit	22.11B	18.49B	29.15B	39.37B	23.20B	39.10B	62.36B	60.46B
Basic EPS	8	6	10	14	9	15	25	24
Diluted EPS	7.57	6.43	10.09	13.77	8.59	14.87	23.86	23.49

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Revenue	42.31B	47.52B	51.24B	59.89B	56.31B	60.80B
Gross profit	34.74B	39.03B	42.04B	48.99B	46.09B	49.47B
Selling & admin expenses	5.04B	5.64B	6.36B	7.11B	5.52B	9.04B
Research & development	12.15B	12.94B	15.14B	17.14B	17.70B	21.66B
Operating profit	17.56B	20.44B	20.54B	24.75B	22.87B	18.78B
Pretax profit	18.38B	20.53B	21.66B	25.35B	21.75B	18.76B
Tax	1.74B	2.20B	18.95B	2.59B	-5.02B	2.91B
Net profit	16.64B	18.34B	2.71B	22.77B	26.77B	15.85B
Basic EPS	7	7	1	9	11	6
Diluted EPS	6.43	7.14	1.05	8.88	10.44	6.18

Balance sheet

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Total current assets	50.48B	66.23B	75.67B	66.67B	59.55B	85.37B	100.05B	108.72B
Cash & ST investments	41.11B	54.86B	61.95B	48.00B	40.74B	65.40B	77.82B	81.59B
Inventory	--	--	--	--	--	--	--	--
Total assets	97.33B	133.38B	159.32B	165.99B	185.73B	229.62B	276.05B	366.02B
Total current liabilities	7.02B	15.05B	14.98B	21.14B	27.03B	31.96B	33.60B	41.84B
Short-term debt	500.00M	800.00M	1.02B	1.13B	1.37B	1.62B	1.94B	2.21B
Long-term debt	--	--	--	--	9.92B	18.39B	28.83B	58.74B
Total liabilities	13,207,000,000.00	32,322,000,000.00	31,026,000,000.00	41,108,000,000.00	60,014,000,000.00	76,455,000,000.00	93,417,000,000.00	148,778,000,000.00
Total equity	84.13B	101.05B	128.29B	124.88B	125.71B	153.17B	182.64B	217.24B
Retained earnings	41.98B	55.69B	77.35B	69.76B	64.80B	82.07B	102.51B	121.18B

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Total current assets	90.23B	73.61B	73.12B	108.72B	109.77B	125.48B
Cash & ST investments	70.23B	47.07B	44.45B	81.59B	81.18B	90.26B
Inventory	--	--	--	--	--	--
Total assets	280.21B	294.74B	303.84B	366.02B	395.25B	449.96B
Total current liabilities	33.89B	37.31B	36.96B	41.84B	46.75B	56.38B
Short-term debt	1.98B	1.98B	2.11B	2.21B	2.41B	2.43B
Long-term debt	28.83B	28.83B	28.83B	58.74B	58.75B	83.66B
Total liabilities	95,184,000,000.00	99,674,000,000.00	109,778,000,000.00	148,778,000,000.00	151,569,000,000.00	188,735,000,000.00
Total equity	185.03B	195.07B	194.07B	217.24B	243.68B	261.22B
Retained earnings	101.33B	106.35B	101.58B	121.18B	144.65B	157.84B

Cash flow

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Operating cash flow	29.27B	36.31B	38.75B	57.68B	50.48B	71.11B	91.33B	115.80B
Depreciation & amortization	4.32B	5.74B	6.86B	7.97B	8.69B	11.18B	15.50B	18.62B
Free cash flow	15.36B	21.21B	23.58B	38.99B	19.29B	44.07B	54.07B	46.11B
Dividends paid	--	--	--	--	0	0	-5.07B	-5.32B
Stock buybacks / issuance	-12.88B	-4.20B	-6.27B	-44.54B	-27.96B	-19.77B	-30.13B	-26.25B
Ending cash balance	10.12B	19.28B	17.95B	16.87B	15.60B	42.83B	45.44B	39.10B

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Operating cash flow	24.03B	25.56B	30.00B	36.21B	32.23B	31.86B
Depreciation & amortization	3.90B	4.34B	4.96B	5.41B	6.00B	6.36B
Free cash flow	11.09B	9.02B	11.17B	14.83B	13.23B	1.75B
Dividends paid	-1.33B	-1.33B	-1.33B	-1.34B	-1.35B	-1.35B
Stock buybacks / issuance	-12.75B	-10.17B	-3.33B	0	0	0
Ending cash balance	30.07B	13.83B	11.94B	39.10B	31.10B	29.27B

Returns & efficiency

Line item	2018	2019	2020	2021	2022	2023	2024	2025
ROE %	27.90	19.96	25.42	31.10	18.52	28.04	37.14	30.24
ROA %	24.32	16.02	19.92	24.21	13.19	18.83	24.66	18.83
ROIC %	27.02	17.31	22.79	28.08	15.79	22.24	28.79	22.44
5-year avg ROE %	18.39	20.11	23.37	25.65	24.58	24.61	28.04	29.01
EBIT margin %	45.44	35.12	38.01	39.65	24.82	35.49	43.39	43.34
FCF / sales %	27.51	30.00	27.49	33.17	16.33	32.50	32.87	22.94
Current ratio	7.19	4.40	5.05	3.15	2.20	2.67	2.98	2.60
Quick ratio	6.94	4.28	4.89	2.94	2.01	2.55	2.82	2.42
Debt / assets	0.51	7.74	6.69	8.36	14.32	16.22	17.77	22.92
LT debt / equity	--	9.42	7.51	10.21	20.06	23.25	25.80	37.60
Interest coverage	2,818.89	1,241.60	--	--	--	107.34	99.83	74.76
Revenue CAGR (3Y) %	46.04	36.76	28.35	28.30	18.15	16.21	11.73	19.89
Net income CAGR (3Y) %	81.67	21.85	22.30	21.20	7.87	10.29	16.57	37.61
FCF CAGR (3Y) %	25.36	22.23	10.49	36.42	-3.12	23.17	11.51	33.71

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
ROE %	39.83	40.65	32.64	30.24	32.93	29.85
ROA %	26.49	27.24	20.89	18.83	20.90	18.29
ROIC %	30.86	31.90	25.13	22.44	24.78	21.89
5-year avg ROE %	--	--	--	--	--	--
EBIT margin %	44.43	45.43	44.91	43.34	42.23	39.24
FCF / sales %	30.71	28.04	23.67	22.94	22.45	17.95
Current ratio	2.66	1.97	1.98	2.60	2.35	2.23
Quick ratio	2.50	1.71	1.67	2.42	2.11	1.99
Debt / assets	17.67	16.81	16.80	22.92	21.95	24.96
LT debt / equity	25.69	24.39	25.22	37.60	34.62	42.07
Interest coverage	91.41	86.32	88.64	74.76	61.06	44.14
Revenue CAGR (3Y) %	--	--	--	--	--	--
Net income CAGR (3Y) %	--	--	--	--	--	--
FCF CAGR (3Y) %	--	--	--	--	--	--

✦ Quant Revenue Concentration how this is computed

Single-engine

Family of Apps is the largest reported line at 99.29% of revenue, across 2 reported segments.
The next-largest line, Reality Labs, is a distant second at 0.71% - a sharp slowdown here would have little to offset it.

Revenue breakdown most recent period

Business

Family of Apps99.29%

Reality Labs0.71%

Quote time 2026-10-20 09:20:15 · For reference only, not investment advice and not tailored to your situation.

Meta Platforms discussion 1 comments

reels_and_capex says:

September 19, 2026 at 9:47 am

capex guidance keeps creeping up every call and the stock still rips afterward, market really has decided it doesn’t care about the ad business funding a moonshot.

Reply